Physician profile
Dharmeshkumar Patel
NPI 1902990336
$5,702.52
in general payments reported to CMS, 2019-2025
43 companies · $852 in 2025
The $852 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $890 · 2020: $792 · 2021: $688 · 2022: $631 · 2023: $996 · 2024: $854 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,702.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $968.31 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $617.18 | 2020-2025 | |
| Lilly USA, LLC | $437.80 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $373.29 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $361.75 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $330.44 | 2019-2025 | |
| Abbott Laboratories | $210.18 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Pfizer INC. | $199.12 | 2019-2025 | |
| Exact Sciences Corporation | $196.06 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $164.68 | 2020-2024 | Xarelto |
| Esperion Therapeutics, INC. | $151.63 | 2020-2025 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $146.75 | 2021-2024 | Rexulti |
| Merck Sharp & Dohme LLC | $137.36 | 2019-2025 | Lagevrio |
| Amgen INC. | $134.89 | 2019-2024 | Krystexxa |
| Amarin Pharma, INC. | $122.90 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharmeshkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.